Droloxifene in Advanced Breast Cancer as Second- or Third-Line Endocrine Therapy: A Phase II Trial

1992 ◽  
Vol 15 (5) ◽  
pp. 368-372
Author(s):  
E. Engel ◽  
U.R. Kleeberg ◽  
N. Marschner ◽  
H.E. Wander ◽  
L. Reichel ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Endocrine Therapy ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Third Line

Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2– Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial

2018 ◽  
Vol 18 (2) ◽  
pp. e197-e203 ◽  
Author(s):  
Tamar Safra ◽  
Bella Kaufman ◽  
Luna Kadouri ◽  
Noa Efrat (Ben-Baruch) ◽  
Larisa Ryvo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Endocrine Therapy ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Open Label ◽  
Open Label Phase

Phase-II Trial of Oral Idarubicin (4-Demethoxydaunorubicin) in Advanced Breast Cancer

1986 ◽  
Vol 9 (4) ◽  
pp. 236-238 ◽  
Author(s):  
H.-E. Wander ◽  
D. Meyer ◽  
P. Schuff-Werner ◽  
G.A. Nagel
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast

scholarly journals Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain

2004 ◽  
Vol 15 (2) ◽  
pp. 201-206 ◽  
Author(s):  
R. Colomer ◽  
A. Llombart-Cussac ◽  
A. Lluch ◽  
A. Barnadas ◽  
B. Ojeda ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Predictive Value ◽  
Phase Ii Trial ◽  
Extracellular Domain ◽  
Advanced Breast

Phase ii trial of D-Trp-6-LH-RH in advanced breast cancer

1987 ◽  
Vol 28 ◽  
pp. 100
Author(s):  
G. Mathe ◽  
R. Helling ◽  
J. Gastlaburu ◽  
M.L.. VoVan ◽  
G. Prévot ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Lh Rh
Sign in / Sign up

Export Citation Format

Share Document